Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.84 USD | -7.43% | -24.30% | -42.34% |
03:00pm | Transcript : Scholar Rock Holding Corporation Presents at UBS Obesity Therapeutics Day, May-23-2024 09:00 AM | |
05-22 | Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SCHOLAR ROCK HOLDING CORPORATION | Bio Therapeutic Drugs | -7.51% | -24.30% | -42.34% | +43.01% | -43.45% | 934M |
- Stock Market
- Equities
- SRRK Stock
- Charts Scholar Rock Holding Corporation
- Relative Strength Chart